Breaking News Instant updates and real-time market news.

VRTU

Virtusa

$49.18

-0.37 (-0.75%)

18:18
03/16/18
03/16
18:18
03/16/18
18:18

Virtusa CSO sells 17,749 common shares

In a regulatory filing, Virtusa EVP and CSO Thomas R. Holler disclosed the sale of 17,749 common shares of the company at a price of $50.5334 per share.

  • 19

    Mar

  • 22

    Mar

VRTU Virtusa
$49.18

-0.37 (-0.75%)

11/17/17
NEED
11/17/17
NO CHANGE
Target $55
NEED
Buy
Virtusa price target raised to $55 from $45 at Needham
Needham analyst Mayank Tandon raised his price target on Virtusa to $55 and kept his Buy rating following meetings with company management. Tandon says the discussion added to his confidence regarding Virtusa's ability to "sustain above-industry revenue growth while continuing to expand operating margins". The analyst says the second half of FY18 and FY19 will show strong top-line growth as a result of strength in the company's core banking vertical along with improving trends in the insurance, healthcare, and telecom segments.
03/13/18
WEDB
03/13/18
NO CHANGE
Target $60
WEDB
Outperform
Virtusa's eTouch purchase to expand FY19 SMAC revenue mix, says Wedbush
Wedbush analyst Moshe Katri maintained raised his price target on Virtusa to $60 from $55 and maintained an Outperform rating on shares following the announcement that Virtusa has acquired eTouch for $140M in cash. In a research note to investors, Katri said he expects the eTouch acquisition to expand the company's FY19's social, mobile, analytics and cloud space revenue mix to 39%. He believes Virtusa's results will continue to benefit from a gradual IT spending recovery in the Financial Services vertical, helping accelerate top-line growth, while scaling margins.
03/14/18
MAXM
03/14/18
NO CHANGE
Target $64
MAXM
Buy
Virtusa price target raised to $64 from $59 at Maxim
Maxim analyst Brian Kinstlinger raised his price target on Virtusa to $64 after the company's latest acquisition of eTouch, adding a west coast presence to its geographic span along with digital capabilities that "diversify its customer concentration". The analyst sees a modest accretion to Virtusa EPS from eTouch deal while also pointing to the benefits of the recent Polaris delisting that should eliminate 19c from Virtusa's minority interest. Kinstlinger keeps his Buy rating on Virtusa and also raises his FY19 EPS view to $2.24 from $2.07 based on the impact of the two deals.
03/15/18
NEED
03/15/18
NO CHANGE
Target $65
NEED
Buy
Virtusa price target raised to $65 from $60 at Needham
Needham analyst Mayank Tandon raised the price target on Virtusa to $65 and kept his Buy rating after the company's acquisition of eTouch Systems announced this week. Tandon contends that the deal is a strong strategic fit, strengthening Virtusa's digital abilities and expanding its presence into the "high-growth" tech arena with revenue stream diversification. The analyst sees upside potential to his estimates from the oneTouch accretion along with "incremental strength" in Virtusa's core business.

TODAY'S FREE FLY STORIES

IWM

iShares Trust Russell 2000 Index Fund

$154.43

-0.89 (-0.57%)

08:17
04/25/18
04/25
08:17
04/25/18
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USG

USG

$40.08

-0.52 (-1.28%)

08:17
04/25/18
04/25
08:17
04/25/18
08:17
Hot Stocks
USG says making strategic progress towards achieving 2020 financial targets »

On slides that will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

VLKAY

Volkswagen

08:17
04/25/18
04/25
08:17
04/25/18
08:17
Upgrade
Volkswagen rating change  »

Volkswagen upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$41.50

1.06 (2.62%)

, AAPL

Apple

$162.87

-2.38 (-1.44%)

08:17
04/25/18
04/25
08:17
04/25/18
08:17
Recommendations
Teradyne, Apple analyst commentary  »

Apple fears appear to…

TER

Teradyne

$41.50

1.06 (2.62%)

AAPL

Apple

$162.87

-2.38 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 16

    May

  • 30

    May

DIA

Diamonds Fund ETF

$240.06

-4.26 (-1.74%)

08:17
04/25/18
04/25
08:17
04/25/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$75.29

-2.91 (-3.72%)

08:17
04/25/18
04/25
08:17
04/25/18
08:17
Conference/Events
PayPal has a conference call hosted by JPMorgan »

JPMorgan Analyst Huang…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 22

    May

  • 23

    May

  • 12

    Jun

SPY

SPDR S&P 500 ETF Trust

$263.12

-3.46 (-1.30%)

08:17
04/25/18
04/25
08:17
04/25/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$29.66

0.84 (2.91%)

08:17
04/25/18
04/25
08:17
04/25/18
08:17
Upgrade
PulteGroup rating change  »

PulteGroup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

XLF

Financial Select Sector

$27.66

-0.195 (-0.70%)

08:17
04/25/18
04/25
08:17
04/25/18
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$97.24

-0.46 (-0.47%)

08:16
04/25/18
04/25
08:16
04/25/18
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

08:16
04/25/18
04/25
08:16
04/25/18
08:16
Hot Stocks
Bombardier wins contract to provide up to 175 FLEXITY trams to STIB »

Bombardier Transportation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

PowerShares QQQ Trust

$158.51

-3.4 (-2.10%)

08:16
04/25/18
04/25
08:16
04/25/18
08:16
Technical Analysis
PowerShares QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRRX

Durect

$2.07

-0.005 (-0.24%)

08:16
04/25/18
04/25
08:16
04/25/18
08:16
Hot Stocks
Durect begins patient dosing in Phase 2a trial of alcoholic hepatitis candidate »

Durect has commenced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 26

    Jun

  • 28

    Jul

$COMP

Nasdaq Composite

08:16
04/25/18
04/25
08:16
04/25/18
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

08:16
04/25/18
04/25
08:16
04/25/18
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZLAB

Zai Lab

$18.06

-2.74 (-13.17%)

08:15
04/25/18
04/25
08:15
04/25/18
08:15
Hot Stocks
Zai Lab, Entasis announce exclusive license agreement in Asia-Pacific »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

AMGN

Amgen

$171.91

-2.75 (-1.57%)

08:15
04/25/18
04/25
08:15
04/25/18
08:15
Recommendations
Amgen analyst commentary  »

Amgen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 17

    May

  • 22

    May

  • 28

    May

ZLAB

Zai Lab

$18.06

-2.74 (-13.17%)

08:14
04/25/18
04/25
08:14
04/25/18
08:14
Hot Stocks
Zai Lab, Entasis announce license agreement for ETX2514 in Asia-Pacific region »

Entasis Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

WYNN

Wynn Resorts

$189.70

-3.54 (-1.83%)

08:13
04/25/18
04/25
08:13
04/25/18
08:13
Hot Stocks
Wynn Resorts sees opening Boston Harbor project in mid-2019 »

With its earnings report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

08:13
04/25/18
04/25
08:13
04/25/18
08:13
Hot Stocks
Dare Bioscience, Juniper emter into exclusive worldwide license agreement »

Dare Bioscience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$189.70

-3.54 (-1.83%)

08:12
04/25/18
04/25
08:12
04/25/18
08:12
Hot Stocks
Wynn Resorts CEO says Boston project not for sale »

Wynn Resorts CEO Matt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

TWTR

Twitter

$30.48

-0.74 (-2.37%)

08:12
04/25/18
04/25
08:12
04/25/18
08:12
Hot Stocks
Twitter CEO says soliciting external experts to improve health of service »

CEO Jack Dorsey said on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

AVXS

AveXis

$210.76

0.77 (0.37%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Hot Stocks
AveXis announces first patient dosed in Phase 3 trial of AVXS-101 »

AveXis announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

PHM

PulteGroup

$29.66

0.84 (2.91%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Upgrade
PulteGroup rating change  »

PulteGroup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

HESM

Hess Midstream Partners

$19.49

-0.92 (-4.51%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Earnings
Hess Midstream Partners reaffirms FY18 net income view $335M-$360M »

Reaffirms FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.